Table 4. Adverse events in the induction phase based on the European Academy of Allergology and Clinical Immunology criteria (N=164).
| Number (%) | |
|---|---|
| No adverse events | 94 (57) |
| Grade 1 | 40 (25) |
| Grade 2 | 23 (14) |
| Grade 3 | 7 (4) |
| Grade 4 | 0 |
| Grade 5 | 0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.